Skip to main content
. 2021 Jan 29;149:e40. doi: 10.1017/S0950268821000236

Table 1.

Baseline characteristics of the included studies

References Study design Sample size (n) Mean age (years) Male (%) HT (%) DM (%) CKD (%) Lymphocytes (109) D-dimer (mcg/ml) Outcome Cut-off for Thrombocytopenia (*109/l) NOS
[8] PO 373 52.78 67 Mortality <150 7
[9] PO 178 64 59.6 32.6 17.4 1.7 1.2 0.56 Severity <100 7
[20] RO 21 56 81 23.8 14.3 0.9 0.5 Severity <100 7
[24] RO 44 >65 (56.8) 36.3 34.1 15.9 Severity <150 7
[25] RO 393 62.2 60.6 50.1 25.2 Dimer >0.5 (36.4) IMV <150 6
[26] RO 1099 47 59.1 15 7.4 0.7 1 Dimer >0.5 (46.4) Severity <150 7
[27] RO 98 55.4 38.8 30.6 9.2 1.4 ICU Care ? 7
[28] RO 41 49 73 15 20 0.8 0.5 ICU Care <100 6
[29] RO 110 56.9 43.6 33.6 26.4 1.4 4.4 Dimer >0.5 (76.3) Severity <140 9
[30] RO 59 64 49 42 15 1.1 6.1 ICU Care <100 7
[10] RO 63 48 85 32 32 6.4 1.1 0.6 Dimer >0.55 (59) ICU Care <125 6
[23] RO 611 64 54 30 16 1 1.24 Severity <100 7
[11] RO 548 60 50.9 30.3 15.1 1.8 - Severity <150 9
[12] RO 1190 57 53.4 26.1 12.2 2.6 1.2 0.9 Mortality <100 9
[13] RO 756 69 62.2 37.8 28.6 13.5 Dimer >0.50 (87.8) Mortality <130 9
[14] RO 113 53.8 62.8 19.5 14.2 5.3 1.2 Mortality <150 7
[15] RO 135 47 53.3 9.6 8.9 1.1 0.4 Severity <125 7
[16] RO 276 51 56.2 17 5.1 1.1 Dimer >0.50 (53.7) Severity <150 7
[17] RO 239 62.5 59.8 43.9 18.4 0.6 Mortality <125 9
[18] RO 1476 58.7 52.3 Mortality <125 8
[19] RO 788 45.8 51.6 16 7.2 0.9 1.2 Severity <100 9
[21] RO 161 45 49.7 13.7 4.3 1.1 Severity <100 7
[22] RO 191 56 62 30 19 1 1 0.8 Dimer >0.50 (68) Mortality <100 7

CKD, chronic kidney disease; DM, diabetes mellitus; HT, hypertension; ICU, intensive care unit; IMV, invasive mechanical ventilation; PO, prospective observational; RO, retrospective observational; NOS, Newcastle−Ottawa scale.